Inactive Instrument

Pernix Therapeutics Holdings Inc Stock

Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company. The Company focuses on identifying, developing and commercializing differentiated products that address unmet medical needs. It focuses on underserved therapeutic areas, such as central nervous system (CNS), including neurology and psychiatry, as well as other specialty therapeutic areas. Its products include Treximet, indicated for acute migraine; Zohydro ER with BeadTek, an extended-release opioid agonist indicated for the management of pain severe; Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance, and Khedezla for major depressive disorder. It promotes selected non-core branded products, such as its cough and cold products, through co-promotion arrangements with third-party sales organizations, and distributes its generic products through its subsidiaries, Macoven Pharmaceuticals, LLC (Macoven) and Cypress Pharmaceuticals, Inc.

Employees

Sector

Pharmaceuticals

More about the company

-40%: Exceptional extension

SEIZE THE OFFER!

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.45%	-1.37%	+43.66%	+141.28%	987B
JOHNSON & JOHNSON	+3.37%	+1.66%	+58.00%	+44.48%	576B
ABBVIE INC.	+2.07%	+5.52%	+27.75%	+72.72%	415B
ROCHE HOLDING AG	+3.50%	-1.30%	+22.76%	+15.66%	320B
ASTRAZENECA PLC	+1.51%	+2.29%	+33.37%	+22.03%	278B
NOVARTIS AG	+0.66%	+2.68%	+30.20%	+39.72%	279B
NOVO NORDISK A/S	-0.17%	+7.58%	-32.19%	-42.85%	208B
AMGEN INC.	+0.66%	-0.24%	+27.37%	+52.79%	187B
GILEAD SCIENCES, INC.	+0.14%	-1.71%	+17.76%	+61.42%	155B
Average	+0.34%	+1.51%	+25.41%	+45.25%	378.36B
Weighted average by Cap.	+0.36%	+0.73%	+33.54%	+66.95%

Pernix Therapeutics Holdings Inc Stock

Stocks

Pharmaceuticals

Other Pharmaceuticals

Company Profile

End-of-day quote OTC Bulletin Board Other stock markets
-	-